Acuitas Investments, LLC Adaptimmune Therapeutics PLC Transaction History

Acuitas Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$0.83 - $1.47 $2,390 - $4,233	2,880 Added 0.53%	541,201 $530,000
Q1 2024 May 10, 2024	BUY	$0.7 - $1.75 $40,972 - $102,431	58,532 Added 12.2%	538,321 $850,000
Q4 2023 Feb 02, 2024	BUY	$0.43 - $0.79 $10 - $19	25 Added 0.01%	479,789 $379,000
Q3 2023 Oct 27, 2023	BUY	$0.73 - $1.04 $350,227 - $498,954	479,764 New	479,764 $374,000

150M

60.8K

5.8K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $108M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuitas Investments, LLC with notifications on news.